NEW YORK (GenomeWeb News) – Bruker BioSpin, a division of Bruker, and Royal Philips Electronics jointly announced today that they have signed a memorandum of understanding to develop Magnetic Particle Imaging scanners for the preclinical market.

The collaboration would combine Philips' strength in medical imaging with Bruker BioSpin's expertise in analytical magnetic resonance instruments and preclinical MRI.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.